✦ LIBER ✦
Tecarfarin, a Novel Vitamin K Reductase Antagonist, Is Not Affected by CYP2C9 and CYP3A4 Inhibition Following Concomitant Administration of Fluconazole in Healthy Participants
✍ Scribed by Bavisotto, Linda M.; Ellis, David J.; Milner, Peter G.; Combs, Daniel L.; Irwin, Ian; Canafax, Daniel M.
- Book ID
- 120006596
- Publisher
- Sage Publications
- Year
- 2011
- Tongue
- English
- Weight
- 267 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0091-2700
No coin nor oath required. For personal study only.